Mylan gains FDA nod for generic migraine therapy

05/17/2013 | Drug Store News

Mylan received federal approval for its zolmitriptan tablets in two strengths, 2.5 mg and 5 mg. The drug, which addresses acute migraine in adults, is a generic form of Zomig by IPR Pharmaceuticals.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN